ERBB2 and cancer: In anothertrial, pretreatment magnetic resonance imaging (MRI)and [64Cu]-DOTA-trastuzumab PET-CT was used to predictthe surgical response to a combination of cytotoxic chemotherapy andthe antibodies trastuzumab and pertuzumab in women with HER2-positivebreast cancer.